CGAS and systemic lupus erythematosus: Specific cGAS inhibitors, including RU.521 and Compound 25, effectively suppress inflammatory initiation through selective cGAS inhibition (Vincent et al., 2017; Tan et al., 2021), showing therapeutic promise in preliminary SLE studies.